IDYA
Price
$22.18
Change
-$0.54 (-2.38%)
Updated
Jan 17 closing price
Capitalization
1.92B
73 days until earnings call
REGN
Price
$681.58
Change
-$11.65 (-1.68%)
Updated
Jan 17 closing price
Capitalization
74.9B
17 days until earnings call
Ad is loading...

IDYA vs REGN

Header iconIDYA vs REGN Comparison
Open Charts IDYA vs REGNBanner chart's image
IDEAYA Biosciences
Price$22.18
Change-$0.54 (-2.38%)
Volume$528.55K
Capitalization1.92B
Regeneron Pharmaceuticals
Price$681.58
Change-$11.65 (-1.68%)
Volume$1.11M
Capitalization74.9B
IDYA vs REGN Comparison Chart
Loading...
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
REGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IDYA vs. REGN commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IDYA is a Hold and REGN is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (IDYA: $22.18 vs. REGN: $681.58)
Brand notoriety: IDYA: Not notable vs. REGN: Notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IDYA: 55% vs. REGN: 127%
Market capitalization -- IDYA: $1.92B vs. REGN: $74.9B
IDYA [@Biotechnology] is valued at $1.92B. REGN’s [@Biotechnology] market capitalization is $74.9B. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IDYA’s FA Score shows that 0 FA rating(s) are green whileREGN’s FA Score has 0 green FA rating(s).

  • IDYA’s FA Score: 0 green, 5 red.
  • REGN’s FA Score: 0 green, 5 red.
According to our system of comparison, REGN is a better buy in the long-term than IDYA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IDYA’s TA Score shows that 2 TA indicator(s) are bullish while REGN’s TA Score has 3 bullish TA indicator(s).

  • IDYA’s TA Score: 2 bullish, 3 bearish.
  • REGN’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, both IDYA and REGN are a bad buy in the short-term.

Price Growth

IDYA (@Biotechnology) experienced а -7.70% price change this week, while REGN (@Biotechnology) price change was -2.20% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.66%, and the average quarterly price growth was -1.92%.

Reported Earning Dates

IDYA is expected to report earnings on May 13, 2025.

REGN is expected to report earnings on May 01, 2025.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
REGN($74.9B) has a higher market cap than IDYA($1.92B). REGN YTD gains are higher at: -4.317 vs. IDYA (-13.696). REGN has higher annual earnings (EBITDA): 5.5B vs. IDYA (-220.54M). REGN has more cash in the bank: 9.8B vs. IDYA (920M). IDYA has less debt than REGN: IDYA (18.8M) vs REGN (2.7B). REGN has higher revenues than IDYA: REGN (13.8B) vs IDYA (3.92M).
IDYAREGNIDYA / REGN
Capitalization1.92B74.9B3%
EBITDA-220.54M5.5B-4%
Gain YTD-13.696-4.317317%
P/E RatioN/A16.86-
Revenue3.92M13.8B0%
Total Cash920M9.8B9%
Total Debt18.8M2.7B1%
FUNDAMENTALS RATINGS
REGN: Fundamental Ratings
REGN
OUTLOOK RATING
1..100
7
VALUATION
overvalued / fair valued / undervalued
1..100
66
Overvalued
PROFIT vs RISK RATING
1..100
49
SMR RATING
1..100
51
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
91
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IDYAREGN
RSI
ODDS (%)
N/A
Bullish Trend 11 days ago
68%
Stochastic
ODDS (%)
Bullish Trend 11 days ago
74%
Bearish Trend 11 days ago
57%
Momentum
ODDS (%)
Bearish Trend 11 days ago
84%
Bullish Trend 11 days ago
67%
MACD
ODDS (%)
Bullish Trend 11 days ago
85%
N/A
TrendWeek
ODDS (%)
Bearish Trend 11 days ago
78%
Bullish Trend 11 days ago
67%
TrendMonth
ODDS (%)
Bearish Trend 11 days ago
82%
Bearish Trend 11 days ago
61%
Advances
ODDS (%)
N/A
Bullish Trend 11 days ago
63%
Declines
ODDS (%)
Bearish Trend 11 days ago
76%
Bearish Trend 20 days ago
51%
BollingerBands
ODDS (%)
N/A
Bearish Trend 11 days ago
56%
Aroon
ODDS (%)
Bearish Trend 11 days ago
80%
Bearish Trend 11 days ago
63%
View a ticker or compare two or three
Ad is loading...
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
REGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MRC14.430.24
+1.69%
MRC Global
RENT8.560.12
+1.36%
Rent the Runway
NTR51.620.12
+0.23%
Nutrien Ltd
RXO25.21-0.36
-1.41%
RXO
GENC16.57-0.32
-1.89%
Gencor Industries

IDYA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IDYA has been loosely correlated with GRI. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if IDYA jumps, then GRI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IDYA
1D Price
Change %
IDYA100%
-2.38%
GRI - IDYA
54%
Loosely correlated
+2.11%
PLRX - IDYA
48%
Loosely correlated
-3.36%
ETNB - IDYA
47%
Loosely correlated
+3.53%
RCKT - IDYA
47%
Loosely correlated
+0.98%
PRME - IDYA
47%
Loosely correlated
+0.70%
More

REGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, REGN has been loosely correlated with IDYA. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if REGN jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To REGN
1D Price
Change %
REGN100%
-1.68%
IDYA - REGN
41%
Loosely correlated
-2.38%
MTNB - REGN
41%
Loosely correlated
+3.02%
TECH - REGN
40%
Loosely correlated
-0.35%
VRTX - REGN
37%
Loosely correlated
+1.21%
INVA - REGN
36%
Loosely correlated
+0.70%
More